SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy
Nuvo Research Inc
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
14101 71 0 NRI
Emcee:  TheBusDriver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
13126Hi Joe There are shorters who need a price decrease to make money, and then theCal Gary-11/12/2003
13125RE : bad link in the last post try this link edition.cnn.com When I read the sCal Gary-11/12/2003
13124nypost.com Posted on Wed, Nov. 12, 2003 Experimental AIDS vaccine fails majoCal Gary-11/12/2003
13123Thanks Jim and others for the recent discussions. Much appreciated.Cal Gary-11/12/2003
13122Awesome links Jim. Thanks very much. Maybe, just maybe, I'll get a bettepadco-11/12/2003
13121Padco, a little material on CD4 - and its place in the immune system... users.raxial-11/12/2003
13120FYI Dimethaid announces filing of preliminary prospectus via COMTEX November 11Tom Johnson-11/11/2003
13119Jef, The point was, DMX had no money either to continue. MBMark Bartlett-11/10/2003
13118thanks Mark. but its been over a year since Oxo ran out of money and Dimethaid jef saunders-11/10/2003
13117<b>"Is this the trial you referred to when you said, "What if I axial-11/9/2003
13116DELETEDaxial-11/9/2003
13115Terrific discussions everyone. eomMontana Wildhack-11/9/2003
13114Oh my gawd Jim, you're a virtual cross-referencing encyclopedia on all thingpadco-11/9/2003
13113Hi, Padco - I'm on the run, but I'd like to quickly address some of youaxial-11/9/2003
13112Hello Jim, I never said you said that this trial "could have predicted&quopadco-11/9/2003
13111Bluejay, AZT should never have been approved -- period. What the trial data diMark Bartlett-11/8/2003
13110Hi, Padco - You've brought forward some good points. Perhaps I can address axial-11/8/2003
13109Jim, first of all thanks for the ongoing research. I've been following it apadco-11/8/2003
13108Joe, Vanderbilt was very impressive, no doubt about it but the phase 3 was not DaveAu-11/8/2003
13107Mark, I think AZT was different because when it was approved there were no otheDaveAu-11/8/2003
13106<b>WF10, advanced AIDS, and HAART: previous trial</b> <i>~~~~axial-11/8/2003
13105<b>Designed to work with HAART: WF10 P3 protocol</b> From the P3 praxial-11/8/2003
13104<b>Objective data - Trial Size in Immune-Based Therapies <i>Immune-axial-11/7/2003
13103Hi Dave - <i>"The WF10 trial was a very small trial - more like a paxial-11/7/2003
13102Dave, I have to absolutely disagree on a number of fronts. 1) If you look at aMark Bartlett-11/7/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News